Literature DB >> 15220662

Tolerance of probiotics and prebiotics.

Philippe Marteau1, Philippe Seksik.   

Abstract

The clinical efficacy of probiotics and prebiotics has been proved in several clinical settings. The authors review their proved or potential side effects. Probiotics as living microorganisms may theoretically be responsible for 4 types of side effects in susceptible individuals: infections, deleterious metabolic activities, excessive immune stimulation, and gene transfer. Very few cases of infection have been observed. These occurred mainly in very sick patients who received probiotic drugs because of severe medical conditions. Prebiotics exert an osmotic effect in the intestinal lumen and are fermented in the colon. They may induce gaseousness and bloating. Abdominal pain and diarrhea only occur with large doses. An increase in gastroesophageal reflux has recently been associated with large daily doses. Tolerance depends on the dose and individual sensitivity factors (probably the presence of irritable bowel syndrome or gastroesophageal reflux), and may be an adaptation to chronic consumption.

Entities:  

Mesh:

Year:  2004        PMID: 15220662     DOI: 10.1097/01.mcg.0000128929.37156.a7

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  16 in total

Review 1.  Drug-induced diarrhea.

Authors:  Bincy Abraham; Joseph H Sellin
Journal:  Curr Gastroenterol Rep       Date:  2007-10

Review 2.  Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing Enterocolitis.

Authors:  Kathene C Johnson-Henry; Thomas R Abrahamsson; Richard You Wu; Philip M Sherman
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

3.  Prebiotic Oligosaccharides: Comparative Evaluation Using In Vitro Cultures of Infants' Fecal Microbiomes.

Authors:  J Stiverson; T Williams; J Chen; S Adams; D Hustead; P Price; J Guerrieri; J Deacon; Z Yu
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

Review 4.  Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review.

Authors:  Nandini Dendukuri; Vania Costa; Maurice McGregor; James M Brophy
Journal:  CMAJ       Date:  2005-07-19       Impact factor: 8.262

5.  Effect of supplements: Probiotics and probiotic plus honey on blood cell counts and serum IgA in patients receiving pelvic radiotherapy.

Authors:  Hajar-Alsadat Mansouri-Tehrani; Mohammad Rabbani-Khorasgani; Sayyed Mohsen Hosseini; Fariborz Mokarian; Hoda Mahdavi; Mahnaz Roayaei
Journal:  J Res Med Sci       Date:  2015-07       Impact factor: 1.852

Review 6.  The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese Individuals.

Authors:  Petra C Vinke; Sahar El Aidy; Gertjan van Dijk
Journal:  Front Nutr       Date:  2017-07-24

Review 7.  Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A Review.

Authors:  Dinesh K Dahiya; Monica Puniya; Umesh K Shandilya; Tejpal Dhewa; Nikhil Kumar; Sanjeev Kumar; Anil K Puniya; Pratyoosh Shukla
Journal:  Front Microbiol       Date:  2017-04-04       Impact factor: 5.640

8.  Genome-wide association mapping of lentil (Lens culinaris Medikus) prebiotic carbohydrates toward improved human health and crop stress tolerance.

Authors:  Nathan Johnson; J Lucas Boatwright; William Bridges; Pushparajah Thavarajah; Shiv Kumar; Emerson Shipe; Dil Thavarajah
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

9.  Phylogenetic identification of bacterial MazF toxin protein motifs among probiotic strains and foodborne pathogens and potential implications of engineered probiotic intervention in food.

Authors:  Xianghe Yan; Joshua B Gurtler; Pina M Fratamico; Jing Hu; Vijay K Juneja
Journal:  Cell Biosci       Date:  2012-11-27       Impact factor: 7.133

10.  Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial.

Authors:  Cristina Buigues; Julio Fernández-Garrido; Leo Pruimboom; Aldert J Hoogland; Rut Navarro-Martínez; Mary Martínez-Martínez; Yolanda Verdejo; Mari Carmen Mascarós; Carlos Peris; Omar Cauli
Journal:  Int J Mol Sci       Date:  2016-06-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.